These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38271220)

  • 1. Elevated 68 Ga-FAPI Activity in Leiomyosarcoma.
    Wang Q; Zhou Y; Chen X
    Clin Nucl Med; 2024 May; 49(5):e197-e198. PubMed ID: 38271220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 68 Ga-FAPI Versus 18 F-FDG PET/CT in Recurrent Undifferentiated Pleomorphic Sarcoma of Colon Mesentery.
    Zhang L; Liu Z; Jiang S; He Q; Zhang R
    Clin Nucl Med; 2022 Oct; 47(10):e651-e653. PubMed ID: 35605050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased 68 Ga-FAPI Activity in Hepatic Inflammatory Myofibroblastoma.
    Ou L; Zhou Y; Sun R; Zhang C; Chen X
    Clin Nucl Med; 2023 Jun; 48(6):522-524. PubMed ID: 37083628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased 68 Ga-FAPI Uptake in Benign Metastasizing Leiomyoma.
    Wu S; Cai J; Chen Q; Wu J; Chen H
    Clin Nucl Med; 2023 Sep; 48(9):809-811. PubMed ID: 37335290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18 F-FDG PET/CT Versus 68 Ga-FAPI PET/CT in a Case of Isolated Nodal-Type Follicular Dendritic Cell Sarcoma.
    Li Z; Qiu L; Xu T; Su D; Chen Y
    Clin Nucl Med; 2024 Mar; 49(3):268-269. PubMed ID: 38048566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Head-to-head evaluation of [
    Gu B; Liu X; Wang S; Xu X; Liu X; Hu S; Yan W; Luo Z; Song S
    Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2889-2901. PubMed ID: 35113192
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Sahin E; Kus T; Aytekin A; Uzun E; Elboga U; Yilmaz L; Cayirli YB; Okuyan M; Cimen V; Cimen U
    J Nucl Med; 2024 Apr; 65(4):512-519. PubMed ID: 38485276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of [
    Chen H; Pang Y; Wu J; Zhao L; Hao B; Wu J; Wei J; Wu S; Zhao L; Luo Z; Lin X; Xie C; Sun L; Lin Q; Wu H
    Eur J Nucl Med Mol Imaging; 2020 Jul; 47(8):1820-1832. PubMed ID: 32222810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of [
    Unterrainer LM; Lindner S; Eismann L; Casuscelli J; Gildehaus FJ; Bui VN; Albert NL; Holzgreve A; Beyer L; Todica A; Brendel M; Cyran CC; Karl A; Stief CG; Ledderose ST; Unterrainer M; Bartenstein P; Wenter V; Kretschmer A
    Eur J Nucl Med Mol Imaging; 2022 Aug; 49(10):3571-3580. PubMed ID: 35325283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-FDG PET/CT and 68Ga-FAPI-04 PET/CT Findings of Abdominal Leiomyosarcoma.
    Güzel Y; Can C; Söğütçü N; Gündeş E; Gündoğan C
    Clin Nucl Med; 2021 Dec; 46(12):e594-e597. PubMed ID: 34735413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical utility of [
    Zhao L; Pang Y; Zheng H; Han C; Gu J; Sun L; Wu H; Wu S; Lin Q; Chen H
    Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3606-3617. PubMed ID: 33792760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superiority of 18 F-FDG PET/CT to 68 GA-FAPI PET/CT in Adrenocortical Tumor Imaging.
    Kaplan İ; Can C; Kepenek F; Ibiloğlu İ; Güzel Y
    Clin Nucl Med; 2023 Jun; 48(6):e307-e309. PubMed ID: 36754357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significantly Higher 68 Ga-FAPI Than 18 F-FDG Uptake by Hidradenocarcinoma of Head and Neck on PET/CT.
    Ding H; Wang Y; Liang J; Liu Y; Chen Y
    Clin Nucl Med; 2024 May; 49(5):466-467. PubMed ID: 38271244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast-Activation Protein PET and Histopathology in a Single-Center Database of 324 Patients and 21 Tumor Entities.
    Hirmas N; Hamacher R; Sraieb M; Ingenwerth M; Kessler L; Pabst KM; Barbato F; Lueckerath K; Kasper S; Nader M; Schildhaus HU; Kesch C; von Tresckow B; Hanoun C; Hautzel H; Aigner C; Glas M; Stuschke M; Kümmel S; Harter P; Lugnier C; Uhl W; Niedergethmann M; Hadaschik B; Grünwald V; Siveke JT; Herrmann K; Fendler WP
    J Nucl Med; 2023 May; 64(5):711-716. PubMed ID: 36581374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [
    Lin R; Lin Z; Chen Z; Zheng S; Zhang J; Zang J; Miao W
    Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2960-2971. PubMed ID: 35462566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of [
    Li C; Tian Y; Chen J; Jiang Y; Xue Z; Xing D; Wen B; He Y
    Eur Radiol; 2023 Apr; 33(4):2779-2791. PubMed ID: 36394603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 68 Ga-FAPI-04 PET/CT for the Evaluation of Cholangiocarcinoma : Comparison With 18 F-FDG PET/CT and Abdominal 68 Ga-FAPI-04 PET/MR.
    Zhang Z; Cheng C; Jiang H; Pan G; Yu Y; Jin G; Zuo C
    Clin Nucl Med; 2024 May; 49(5):409-418. PubMed ID: 38465929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Added Value of
    Gu B; Xu X; Zhang J; Ou X; Xia Z; Guan Q; Hu S; Yang Z; Song S
    J Nucl Med; 2022 Jun; 63(6):875-881. PubMed ID: 34593594
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of
    Elboga U; Sahin E; Kus T; Cayirli YB; Aktas G; Okuyan M; Cinkir HY; Teker F; Sever ON; Aytekin A; Yılmaz L; Aytekin A; Cimen U; Mumcu V; Kilbas B; Eryilmaz K; Cakici D; Celen YZ
    Mol Imaging Biol; 2022 Oct; 24(5):789-797. PubMed ID: 35411447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Head-to-Head Comparison of [
    Ballal S; Yadav MP; Roesch F; Raju S; Satapathy S; Sheokand P; Moon ES; Martin M; Awarwal S; Tripathi M; Bal C
    Thyroid; 2023 Aug; 33(8):974-982. PubMed ID: 37171126
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.